These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 32367358

  • 1. A Plaque Reduction Neutralization Test for the Detection of ZIKV-Specific Antibodies.
    Dimitrova K, Mendoza EJ, Mueller N, Wood H.
    Methods Mol Biol; 2020; 2142():59-71. PubMed ID: 32367358
    [Abstract] [Full Text] [Related]

  • 2. Analysis of Serum Anti-Zika Virus Antibodies by Focus Reduction Neutralization Test.
    Smith JL, Hirsch AJ.
    Methods Mol Biol; 2020; 2142():73-80. PubMed ID: 32367359
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE, Boroughs KL, Laven J, Stovall JL, Luy BE, Kosoy OI, Huang CY.
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection.
    Shan C, Ortiz DA, Yang Y, Wong SJ, Kramer LD, Shi PY, Loeffelholz MJ, Ren P.
    J Clin Microbiol; 2017 Oct; 55(10):3028-3036. PubMed ID: 28768729
    [Abstract] [Full Text] [Related]

  • 6. Development of Zika Virus Serological Testing Strategies in New York State.
    Lee WT, Wong SJ, Kulas KE, Dupuis AP, Payne AF, Kramer LD, Dean AB, St George K, White JL, Sommer JN, Ledizet M, Limberger RJ.
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
    [Abstract] [Full Text] [Related]

  • 7. Zika Virus and the World Health Organization Criteria for Determining Recent Infection Using Plaque Reduction Neutralization Testing.
    Ward MJ, Alger J, Berrueta M, Bock H, Buekens P, Cafferata ML, Ciganda A, García J, García K, Lopez W, Lorenzana I, Parham L, Wesson DM.
    Am J Trop Med Hyg; 2018 Sep; 99(3):780-782. PubMed ID: 29943723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serological evidence of Zika virus infection in non-human primates in Zambia.
    Wastika CE, Sasaki M, Yoshii K, Anindita PD, Hang'ombe BM, Mweene AS, Kobayashi S, Kariwa H, Carr MJ, Hall WW, Eshita Y, Orba Y, Sawa H.
    Arch Virol; 2019 Aug; 164(8):2165-2170. PubMed ID: 31154511
    [Abstract] [Full Text] [Related]

  • 10. Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV Antibodies in Neonates With Congenital Disease.
    Cordeiro MT, Brito CA, Pena LJ, Castanha PM, Gil LH, Lopes KG, Dhalia R, Meneses JA, Ishigami AC, Mello LM, Alencar LX, Guarines KM, Rodrigues LC, Marques ET.
    J Infect Dis; 2016 Dec 15; 214(12):1897-1904. PubMed ID: 27923950
    [Abstract] [Full Text] [Related]

  • 11. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
    Whitbeck JC, Thomas A, Kadash-Edmondson K, Grinyo-Escuer A, Stafford LJ, Cheng C, Liao GC, Holtsberg FW, Aman MJ, Simmons G, Davidson E, Doranz BJ.
    PLoS Negl Trop Dis; 2020 Nov 15; 14(11):e0008730. PubMed ID: 33206639
    [Abstract] [Full Text] [Related]

  • 12. Zika Virus Peptide ELISA (ZIKV-NS2B-Concat ELISA) for Detection of IgG Antibodies to Zika Virus Infection.
    Mishra N, Thakkar R, Ng J, Lipkin WI.
    Methods Mol Biol; 2020 Nov 15; 2142():113-122. PubMed ID: 32367363
    [Abstract] [Full Text] [Related]

  • 13. Development of a high-throughput colorimetric Zika virus infection assay.
    Müller JA, Harms M, Schubert A, Mayer B, Jansen S, Herbeuval JP, Michel D, Mertens T, Vapalahti O, Schmidt-Chanasit J, Münch J.
    Med Microbiol Immunol; 2017 Apr 15; 206(2):175-185. PubMed ID: 28176006
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Zika Virus Antibody Titers Three Years after Confirmed Infection.
    Langerak T, Kasbergen LMR, Chandler F, Brinkman T, Faerber Z, Phalai K, Ulbert S, Rockstroh A, Bruin E, Koopmans MPG, Rockx B, van Gorp ECM, Vreden S.
    Viruses; 2021 Jul 12; 13(7):. PubMed ID: 34372551
    [Abstract] [Full Text] [Related]

  • 17. Structural Basis of Zika Virus Specific Neutralization in Subsequent Flavivirus Infections.
    Sevvana M, Rogers TF, Miller AS, Long F, Klose T, Beutler N, Lai YC, Parren M, Walker LM, Buda G, Burton DR, Rossmann MG, Kuhn RJ.
    Viruses; 2020 Nov 24; 12(12):. PubMed ID: 33255202
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT, Moi ML, Le TQM, Nguyen TTT, Vu TBH, Nguyen HT, Pham TTH, Le THT, Nguyen LMH, Phu Ly MH, Ng CFS, Takemura T, Morita K, Hasebe F.
    BMC Infect Dis; 2020 May 11; 20(1):332. PubMed ID: 32393198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.